Modulation of the humoral immune response by targeting CD40 and FcγRII/III; delivery of soluble but not particulate antigen to CD40 enhances antibody responses with a Th1 bias

被引:4
|
作者
Szekeres, Zsuzsanna [1 ]
Herbath, Melinda [2 ]
Szittner, Zoltan [2 ]
Papp, Krisztian [1 ]
Erdei, Anna [1 ,2 ]
Prechl, Kizsef [1 ]
机构
[1] Hungarian Acad Sci, Immunol Res Grp, H-1117 Budapest, Hungary
[2] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary
关键词
Antigen; Targeting; scFv; Streptavidin; Nanoparticles; CD40; Fc gamma RII/III; IN-VIVO; B-CELLS; DENDRITIC CELLS; CLASS-II; T-CELLS; VACCINE; LIGAND; ANTITUMOR; ACTIVATION; TOLERANCE;
D O I
10.1016/j.molimm.2011.08.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Targeted delivery of antigen improves immunogenicity and can obviate the use of adjuvants. In addition to molecular targeting based on affinity interactions, particle-based antigen targeting to myeloid cells is also an efficient means to enhance immune responses. We compared the efficiency of targeting a model antigen, streptavidin, to CD40 and low affinity Fc gamma receptors II and III, either in a soluble or in a particulate form. Single chain fragments targeting these receptors were used to generate soluble tetramers with streptavidin or to decorate streptavidin coated nanobeads, and mice were immunized with the different formulations. Whereas particulate presentation of streptavidin enhanced total IgG1 and IgG2a levels, overall antigen specific antibody production increased in the case of targeted soluble antigen only, as assessed by reverse protein arrays and ELISPOT. In particular, soluble CD40 targeted antigen induced the strongest IgG2a responses, suggesting a Th1 bias compared to FcgammaRII/III targeting. Combined targeting to these receptors did not further increase immunogenicity. Thus, in our model, affinity targeting of soluble antigen to CD40 proved to be superior to particle-mediated delivery both in terms of antibody quantity and quality. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:155 / 162
页数:8
相关论文
共 9 条
  • [1] Doxorubicin enhances CD4+ T-cell immune responses by inducing expression of CD40 ligand and 4-1BB
    Park, Jae Yeo
    Jang, Min Ja
    Chung, Yoon Hee
    Kim, Kyung Yong
    Kim, Sung Su
    Lee, Won Bok
    You, Seungkwon
    Choi, Youn Seok
    Hur, Dae Young
    Kim, Daejin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (13-14) : 1530 - 1539
  • [2] CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1
    Pilon, Caroline
    Levast, Benoit
    Meurens, Francois
    Le Vern, Yves
    Kerboeuf, Dominique
    Salmon, Henry
    Velge-Roussel, Florence
    Lebranchu, Yvon
    Baron, Christophe
    MOLECULAR IMMUNOLOGY, 2009, 46 (03) : 437 - 447
  • [3] Incomplete Freund's adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
    Pollack, Karlyn E.
    Meneveau, Max O.
    Melssen, Marit M.
    Lynch, Kevin T.
    Koeppel, Alexander F.
    Young, Samuel J.
    Turner, Stephen
    Kumar, Pankaj
    Sol-Church, Katia
    Mauldin, Ileana S.
    Slingluff, Craig L., Jr.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [4] Antibody to CD40 ligand inhibits both humoral and cellular immune responses to adenoviral vectors and facilitates repeated administration to mouse airway
    Scaria, A
    StGeorge, JA
    Gregory, RJ
    Noelle, RJ
    Wadsworth, SC
    Smith, AE
    Kaplan, JM
    GENE THERAPY, 1997, 4 (06) : 611 - 617
  • [5] Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
    Gomez, Carmen E.
    Najera, Jose L.
    Sanchez, Raquel
    Jimenez, Victoria
    Esteban, Mariano
    VACCINE, 2009, 27 (24) : 3165 - 3174
  • [6] Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
    Wenthe, Jessica
    Eriksson, Emma
    Hellstroem, Ann-Charlotte
    Moreno, Rafael
    Ullenhag, Gustav
    Alemany, Ramon
    Lovgren, Tanja
    Loskog, Angelica
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [7] Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models
    Jessica Wenthe
    Emma Eriksson
    Ann-Charlotte Hellström
    Rafael Moreno
    Gustav Ullenhag
    Ramon Alemany
    Tanja Lövgren
    Angelica Loskog
    Journal of Translational Medicine, 21
  • [8] B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: Modulation by BCR and CD40, and relevance to T-independent antibody responses
    Pone, Egest J.
    Lou, Zheng
    Lam, Tonika
    Greenberg, Milton L.
    Wang, Rui
    Xu, Zhenming
    Casali, Paolo
    AUTOIMMUNITY, 2015, 48 (01) : 1 - 12
  • [9] Superiority in Rhesus Macaques of Targeting HIV-1 Env gp140 to CD40 versus LOX-1 in Combination with Replication-Competent NYVAC-KC for Induction of Env-Specific Antibody and T Cell Responses
    Zurawski, Gerard
    Shen, Xiaoying
    Zurawski, Sandra
    Tomaras, Georgia D.
    Montefiori, David C.
    Roederer, Mario
    Ferrari, Guido
    Lacabaratz, Christine
    Klucar, Peter
    Wang, Zhiqing
    Foulds, Kathryn E.
    Kao, Shing-Fen
    Yu, Xuesong
    Sato, Alicia
    Yates, Nicole L.
    LaBranche, Celia
    Stanfield-Oakley, Sherry
    Kibler, Karen
    Jacobs, Bertram
    Salazar, Andres
    Self, Steve
    Fulp, William
    Gottardo, Raphael
    Galmin, Lindsey
    Weiss, Deborah
    Cristillo, Anthony
    Pantaleo, Giuseppe
    Levy, Yves
    JOURNAL OF VIROLOGY, 2017, 91 (09)